Hello, everyone. Nice to see you again. We are off to an early start this morning in order to hustle one of the short people off to the schoolhouse - we love challenges, don't you? So while we all prepare for the day ahead, here are a few items to help you get going. Whatever your own challenges, we hope you conquer them. Have a good one...
Pfizer To Co-Promote Takeda's Actos In China (Bloomberg News)
Elan Drops Doses From Alzheimer's Trial After Deaths (Reuters)
Seattle Genetics Sell Foreign Rights To Drug To Takeda (Reuters)
Sanofi-Pasteur Plans Layoffs In PA (Allentown Morning Call)
Addex Suspends Migraine Drug Study (PharmaTimes)